{
    "Trade/Device Name(s)": [
        "AggreGuide A-100 AA assay",
        "AggreGuide A-100 Instrument"
    ],
    "Submitter Information": "Aggredyne, Inc.",
    "510(k) Number": "K163274",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122162"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JOZ"
    ],
    "Summary Letter Date": "November 18, 2016",
    "Summary Letter Received Date": "November 21, 2016",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.5700"
    ],
    "Regulation Name(s)": [
        "Automated platelet aggregation system"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "Platelet function"
    ],
    "Specimen Type(s)": [
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "3.2% sodium citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "AggreGuide A-100 Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Laser light scattering",
        "Platelet aggregation"
    ],
    "Methodologies": [
        "Platelet aggregation test"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Aggredyne AggreGuide A-100 AA assay and instrument for detecting platelet dysfunction via laser light scattering in citrated whole blood.",
    "Indications for Use Summary": "A qualitative system to aid in the detection of platelet dysfunction due to aspirin ingestion in individuals 18 years or older using 3.2% citrated venous whole blood; not for use in patients with congenital or non-aspirin induced platelet abnormalities or those receiving non-aspirin anti-platelet agents.",
    "fda_folder": "Hematology"
}